<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>371-MYCOPHENOLATE-MOFETIL.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="MYCOPHENOLATE MOFETIL" rxcui="7145">
<ATC code="L04AA06" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="PROTON PUMP INHIBITORS" code="A02BC-001" /></DRUG2>
<DESCRIPTION>Decrease of the concentrations of the mycophenolic acid by about a third, with potential risk of reduction of effectiveness</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>371-MYCOPHENOLATE-MOFETIL.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="MYCOPHENOLATE MOFETIL" rxcui="7145">
<ATC code="L04AA06" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="FLUOROQUINOLONES" code="J01MA-001" /></DRUG2>
<DESCRIPTION>Decrease of the concentrations of the mycophenolic acid by about a third, with potential risk of reduction of effectiveness</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>371-MYCOPHENOLATE-MOFETIL.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="MYCOPHENOLATE MOFETIL" rxcui="7145">
<ATC code="L04AA06" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="AMINOPENICILLINS" code="J01CA" /></DRUG2>
<DESCRIPTION>Decrease of the concentrations of the mycophenolic acid by about a third, with potential risk of reduction of effectiveness</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>371-MYCOPHENOLATE-MOFETIL.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="MYCOPHENOLATE MOFETIL" rxcui="7145">
<ATC code="L04AA06" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="ATTENUATED LIVE VIRUS VACCINES" code="J07B-001" /></DRUG2>
<DESCRIPTION>Risk of general vaccine disease, possibly fatal.

</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
<COMMENT>And during the 3 months following the end of the treatment</COMMENT>
</INTERACTION>
</INTERACTIONS>
